Global Sevelamer Market Growth 2018-2023


    Table of Contents

      2018-2023 Global Sevelamer Consumption Market Report

        1 Scope of the Report

        • 1.1 Market Introduction
        • 1.2 Research Objectives
        • 1.3 Years Considered
        • 1.4 Market Research Methodology
        • 1.5 Economic Indicators
        • 1.6 Currency Considered

        2 Executive Summary

        • 2.1 World Market Overview
          • 2.1.1 Global Sevelamer Consumption 2013-2023
          • 2.1.2 Sevelamer Consumption CAGR by Region
        • 2.2 Sevelamer Segment by Type
          • 2.2.1 Tablet
          • 2.2.2 Oral suspension
        • 2.3 Sevelamer Consumption by Type
          • 2.3.1 Global Sevelamer Consumption Market Share by Type (2013-2018)
          • 2.3.2 Global Sevelamer Revenue and Market Share by Type (2013-2018)
          • 2.3.3 Global Sevelamer Sale Price by Type (2013-2018)
        • 2.4 Sevelamer Segment by Application
          • 2.4.1 Adult
          • 2.4.2 Pediatric
        • 2.5 Sevelamer Consumption by Application
          • 2.5.1 Global Sevelamer Consumption Market Share by Application (2013-2018)
          • 2.5.2 Global Sevelamer Value and Market Share by Application (2013-2018)
          • 2.5.3 Global Sevelamer Sale Price by Application (2013-2018)

        3 Global Sevelamer by Players

        • 3.1 Global Sevelamer Sales Market Share by Players
          • 3.1.1 Global Sevelamer Sales by Players (2016-2018)
          • 3.1.2 Global Sevelamer Sales Market Share by Players (2016-2018)
        • 3.2 Global Sevelamer Revenue Market Share by Players
          • 3.2.1 Global Sevelamer Revenue by Players (2016-2018)
          • 3.2.2 Global Sevelamer Revenue Market Share by Players (2016-2018)
        • 3.3 Global Sevelamer Sale Price by Players
        • 3.4 Global Sevelamer Manufacturing Base Distribution, Sales Area, Product Types by Players
          • 3.4.1 Global Sevelamer Manufacturing Base Distribution and Sales Area by Players
          • 3.4.2 Players Sevelamer Products Offered
        • 3.5 Market Concentration Rate Analysis
          • 3.5.1 Competition Landscape Analysis
          • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
        • 3.6 New Products and Potential Entrants
        • 3.7 Mergers & Acquisitions, Expansion

        4 Sevelamer by Regions

        • 4.1 Sevelamer by Regions
          • 4.1.1 Global Sevelamer Consumption by Regions
          • 4.1.2 Global Sevelamer Value by Regions
        • 4.2 Americas Sevelamer Consumption Growth
        • 4.3 APAC Sevelamer Consumption Growth
        • 4.4 Europe Sevelamer Consumption Growth
        • 4.5 Middle East & Africa Sevelamer Consumption Growth

        5 Americas

        • 5.1 Americas Sevelamer Consumption by Countries
          • 5.1.1 Americas Sevelamer Consumption by Countries (2013-2018)
          • 5.1.2 Americas Sevelamer Value by Countries (2013-2018)
        • 5.2 Americas Sevelamer Consumption by Type
        • 5.3 Americas Sevelamer Consumption by Application
        • 5.4 United States
        • 5.5 Canada
        • 5.6 Mexico
        • 5.7 Key Economic Indicators of Few Americas Countries

        6 APAC

        • 6.1 APAC Sevelamer Consumption by Countries
          • 6.1.1 APAC Sevelamer Consumption by Countries (2013-2018)
          • 6.1.2 APAC Sevelamer Value by Countries (2013-2018)
        • 6.2 APAC Sevelamer Consumption by Type
        • 6.3 APAC Sevelamer Consumption by Application
        • 6.4 China
        • 6.5 Japan
        • 6.6 Korea
        • 6.7 Southeast Asia
        • 6.8 India
        • 6.9 Australia
        • 6.10 Key Economic Indicators of Few APAC Countries

        7 Europe

        • 7.1 Europe Sevelamer by Countries
          • 7.1.1 Europe Sevelamer Consumption by Countries (2013-2018)
          • 7.1.2 Europe Sevelamer Value by Countries (2013-2018)
        • 7.2 Europe Sevelamer Consumption by Type
        • 7.3 Europe Sevelamer Consumption by Application
        • 7.4 Germany
        • 7.5 France
        • 7.6 UK
        • 7.7 Italy
        • 7.8 Russia
        • 7.9 Spain
        • 7.10 Key Economic Indicators of Few Europe Countries

        8 Middle East & Africa

        • 8.1 Middle East & Africa Sevelamer by Countries
          • 8.1.1 Middle East & Africa Sevelamer Consumption by Countries (2013-2018)
          • 8.1.2 Middle East & Africa Sevelamer Value by Countries (2013-2018)
        • 8.2 Middle East & Africa Sevelamer Consumption by Type
        • 8.3 Middle East & Africa Sevelamer Consumption by Application
        • 8.4 Egypt
        • 8.5 South Africa
        • 8.6 Israel
        • 8.7 Turkey
        • 8.8 GCC Countries

        9 Market Drivers, Challenges and Trends

        • 9.1 Market Drivers and Impact
          • 9.1.1 Growing Demand from Key Regions
          • 9.1.2 Growing Demand from Key Applications and Potential Industries
        • 9.2 Market Challenges and Impact
        • 9.3 Market Trends

        10 Marketing, Distributors and Customer

        • 10.1 Sales Channel
          • 10.1.1 Direct Marketing
          • 10.1.2 Indirect Marketing
        • 10.2 Sevelamer Distributors
        • 10.3 Sevelamer Customer

        11 Global Sevelamer Market Forecast

        • 11.1 Global Sevelamer Consumption Forecast (2018-2023)
        • 11.2 Global Sevelamer Forecast by Regions
          • 11.2.1 Global Sevelamer Forecast by Regions (2018-2023)
          • 11.2.2 Global Sevelamer Value Forecast by Regions (2018-2023)
          • 11.2.3 Americas Consumption Forecast
          • 11.2.4 APAC Consumption Forecast
          • 11.2.5 Europe Consumption Forecast
          • 11.2.6 Middle East & Africa Consumption Forecast
        • 11.3 Americas Forecast by Countries
          • 11.3.1 United States Market Forecast
          • 11.3.2 Canada Market Forecast
          • 11.3.3 Mexico Market Forecast
          • 11.3.4 Brazil Market Forecast
        • 11.4 APAC Forecast by Countries
          • 11.4.1 China Market Forecast
          • 11.4.2 Japan Market Forecast
          • 11.4.3 Korea Market Forecast
          • 11.4.4 Southeast Asia Market Forecast
          • 11.4.5 India Market Forecast
          • 11.4.6 Australia Market Forecast
        • 11.5 Europe Forecast by Countries
          • 11.5.1 Germany Market Forecast
          • 11.5.2 France Market Forecast
          • 11.5.3 UK Market Forecast
          • 11.5.4 Italy Market Forecast
          • 11.5.5 Russia Market Forecast
          • 11.5.6 Spain Market Forecast
        • 11.6 Middle East & Africa Forecast by Countries
          • 11.6.1 Egypt Market Forecast
          • 11.6.2 South Africa Market Forecast
          • 11.6.3 Israel Market Forecast
          • 11.6.4 Turkey Market Forecast
          • 11.6.5 GCC Countries Market Forecast
        • 11.7 Global Sevelamer Forecast by Type
        • 11.8 Global Sevelamer Forecast by Application

        12 Key Players Analysis

        • 12.1 Sanofi
          • 12.1.1 Company Details
          • 12.1.2 Sevelamer Product Offered
          • 12.1.3 Sanofi Sevelamer Sales, Revenue, Price and Gross Margin (2016-2018)
          • 12.1.4 Main Business Overview
          • 12.1.5 Sanofi News
        • 12.2 Impax Laboratories
          • 12.2.1 Company Details
          • 12.2.2 Sevelamer Product Offered
          • 12.2.3 Impax Laboratories Sevelamer Sales, Revenue, Price and Gross Margin (2016-2018)
          • 12.2.4 Main Business Overview
          • 12.2.5 Impax Laboratories News
        • 12.3 InvaGen Pharmaceuticals
          • 12.3.1 Company Details
          • 12.3.2 Sevelamer Product Offered
          • 12.3.3 InvaGen Pharmaceuticals Sevelamer Sales, Revenue, Price and Gross Margin (2016-2018)
          • 12.3.4 Main Business Overview
          • 12.3.5 InvaGen Pharmaceuticals News
        • 12.4 Dr. Reddy's Laboratories
          • 12.4.1 Company Details
          • 12.4.2 Sevelamer Product Offered
          • 12.4.3 Dr. Reddy's Laboratories Sevelamer Sales, Revenue, Price and Gross Margin (2016-2018)
          • 12.4.4 Main Business Overview
          • 12.4.5 Dr. Reddy's Laboratories News
        • 12.5 Aurobindo Pharma
          • 12.5.1 Company Details
          • 12.5.2 Sevelamer Product Offered
          • 12.5.3 Aurobindo Pharma Sevelamer Sales, Revenue, Price and Gross Margin (2016-2018)
          • 12.5.4 Main Business Overview
          • 12.5.5 Aurobindo Pharma News
        • 12.6 Amneal Pharmaceuticals
          • 12.6.1 Company Details
          • 12.6.2 Sevelamer Product Offered
          • 12.6.3 Amneal Pharmaceuticals Sevelamer Sales, Revenue, Price and Gross Margin (2016-2018)
          • 12.6.4 Main Business Overview
          • 12.6.5 Amneal Pharmaceuticals News

        ...

          13 Research Findings and Conclusion

          Sevelamer (rINN) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is currently marketed by Sanofi under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate).

          According to this study, over the next five years the Sevelamer market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Sevelamer business, shared in Chapter 3.

          This report presents a comprehensive overview, market shares, and growth opportunities of Sevelamer market by product type, application, key manufacturers and key regions and countries.

          This study considers the Sevelamer value and volume generated from the sales of the following segments:

          Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7.
          Tablet
          Oral suspension
          Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2023 in section 11.8.
          Adult
          Pediatric

          This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
          Americas
          United States
          Canada
          Mexico
          Brazil
          APAC
          China
          Japan
          Korea
          Southeast Asia
          India
          Australia
          Europe
          Germany
          France
          UK
          Italy
          Russia
          Spain
          Middle East & Africa
          Egypt
          South Africa
          Israel
          Turkey
          GCC Countries

          The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
          Sanofi
          Impax Laboratories
          InvaGen Pharmaceuticals
          Dr. Reddy's Laboratories
          Aurobindo Pharma
          Amneal Pharmaceuticals
          ...

          In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

          Research objectives
          To study and analyze the global Sevelamer consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
          To understand the structure of Sevelamer market by identifying its various subsegments.
          Focuses on the key global Sevelamer manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
          To analyze the Sevelamer with respect to individual growth trends, future prospects, and their contribution to the total market.
          To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
          To project the consumption of Sevelamer submarkets, with respect to key regions (along with their respective key countries).
          To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
          To strategically profile the key players and comprehensively analyze their growth strategies.



          Summary:
          Sevelamer Market Research Report is about Sevelamer Industry study. Get complete Sevelamer market research report published after Market Study, Industrial Analysis with Trends & Statistics. Sevelamer Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



          REPORT YOU MIGHT BE INTERESTED